Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation.

Morlock GP, Tyrrell FC, Baynham D, Escuyer VE, Green N, Kim Y, Longley-Olson PA, Parrish N, Pennington C, Tan D, Austin B, Posey JE.

Tuberc Res Treat. 2017;2017:3748163. doi: 10.1155/2017/3748163. Epub 2017 Nov 8.

2.

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.

Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE.

Antimicrob Agents Chemother. 2011 May;55(5):2032-41. doi: 10.1128/AAC.01550-10. Epub 2011 Feb 7.

3.

Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis.

Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE.

J Clin Microbiol. 2010 Nov;48(11):4003-9. doi: 10.1128/JCM.00812-10. Epub 2010 Sep 1.

4.

Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005.

Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, Crawford JT, Lobue PA.

Clin Infect Dis. 2008 Jul 15;47(2):168-75. doi: 10.1086/589240.

PMID:
18532886
5.

Multiphasic approach reveals genetic diversity of environmental and patient isolates of Mycobacterium mucogenicum and Mycobacterium phocaicum associated with an outbreak of bacteremias at a Texas hospital.

Cooksey RC, Jhung MA, Yakrus MA, Butler WR, Ad├ękambi T, Morlock GP, Williams M, Shams AM, Jensen BJ, Morey RE, Charles N, Toney SR, Jost KC Jr, Dunbar DF, Bennett V, Kuan M, Srinivasan A.

Appl Environ Microbiol. 2008 Apr;74(8):2480-7. doi: 10.1128/AEM.02476-07. Epub 2008 Feb 29.

6.

Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon.

Cooksey RC, de Waard JH, Yakrus MA, Rivera I, Chopite M, Toney SR, Morlock GP, Butler WR.

Int J Syst Evol Microbiol. 2004 Nov;54(Pt 6):2385-91.

PMID:
15545488
7.

Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Cardoso RF, Cooksey RC, Morlock GP, Barco P, Cecon L, Forestiero F, Leite CQ, Sato DN, Shikama Mde L, Mamizuka EM, Hirata RD, Hirata MH.

Antimicrob Agents Chemother. 2004 Sep;48(9):3373-81.

9.

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.

Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC.

Antimicrob Agents Chemother. 2003 Dec;47(12):3799-805.

10.

Identifying Mycobacterium species and strain typing using a microfluidic labchip instrument.

Cooksey RC, Limor J, Morlock GP, Crawford JT.

Biotechniques. 2003 Oct;35(4):786-94.

11.

Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis.

Silva MS, Senna SG, Ribeiro MO, Valim AR, Telles MA, Kritski A, Morlock GP, Cooksey RC, Zaha A, Rossetti ML.

J Clin Microbiol. 2003 Sep;41(9):4471-4.

12.

Isolation and identification of mycobacteria from livestock specimens and milk obtained in Brazil.

Leite CQ, Anno IS, Leite SR, Roxo E, Morlock GP, Cooksey RC.

Mem Inst Oswaldo Cruz. 2003 Apr;98(3):319-23. Epub 2003 Jul 18.

14.

Simultaneous infection with multiple strains of Mycobacterium tuberculosis.

Braden CR, Morlock GP, Woodley CL, Johnson KR, Colombel AC, Cave MD, Yang Z, Valway SE, Onorato IM, Crawford JT.

Clin Infect Dis. 2001 Sep 15;33(6):e42-7. Epub 2001 Aug 6.

PMID:
11512106
16.

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Hannan MM, Desmond EP, Morlock GP, Mazurek GH, Crawford JT.

J Clin Microbiol. 2001 Feb;39(2):647-50.

17.

Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.

Morlock GP, Plikaytis BB, Crawford JT.

Antimicrob Agents Chemother. 2000 Dec;44(12):3298-301.

18.

Transmission of Mycobacterium tuberculosis from medical waste.

Johnson KR, Braden CR, Cairns KL, Field KW, Colombel AC, Yang Z, Woodley CL, Morlock GP, Weber AM, Boudreau AY, Bell TA, Onorato IM, Valway SE, Stehr-Green PA.

JAMA. 2000 Oct 4;284(13):1683-8.

PMID:
11015799
19.

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Morlock GP, Crawford JT, Butler WR, Brim SE, Sikes D, Mazurek GH, Woodley CL, Cooksey RC.

Antimicrob Agents Chemother. 2000 Sep;44(9):2291-5.

20.

Identification of Mycobacterium species by PCR-restriction fragment length polymorphism analyses using fluorescence capillary electrophoresis.

Hernandez SM, Morlock GP, Butler WR, Crawford JT, Cooksey RC.

J Clin Microbiol. 1999 Nov;37(11):3688-92.

21.
22.
23.

Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.

Cooksey RC, Morlock GP, McQueen A, Glickman SE, Crawford JT.

Antimicrob Agents Chemother. 1996 May;40(5):1186-8.

24.

Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium.

Cooksey RC, Morlock GP, Beggs M, Crawford JT.

Antimicrob Agents Chemother. 1995 Mar;39(3):754-6.

Supplemental Content

Loading ...
Support Center